Cronos Group Inc. ($CRON) Stock Forecast: Up 5.1% Today

What is Cronos Group Inc.?

Cronos Group Inc. (CRON) is a cannabis company that has been navigating through a volatile market with mixed investor sentiments.

Why is Cronos Group Inc. going up?

CRON stock is up 5.1% on Feb 3, 2026 20:12

• The bullish movement in CRON today can be attributed to the launch of its premium cannabis brand, Lord Jones®, in Israel. This strategic expansion into new markets with high-quality products showcases the company's commitment to growth and innovation.
• Additionally, the bullish thesis surrounding potential regulatory changes in the US, specifically the reclassification of marijuana as a Schedule III substance, has likely fueled investor optimism. This shift could lead to improved financial performance for CRON by reducing tax burdens and enhancing operational efficiency.
• Despite recent declines and cautious Wall Street analyst ratings, CRON's forward-thinking approach to product strategy and potential regulatory tailwinds seem to have resonated positively with investors, driving the stock's bullish momentum today.

CRON Price Chart

CRON Technical Analysis

CRON News

Cronos Group: Tobacco Cash, Cannabis Crossroads and a Stock Market in Waiting

Cronos Group's stock has seen a decline recently, despite the company having substantial cash from Altria and no debt. Investors are trying to determine if the cannabis stock is an undervalued opportunity or a slow-moving trap, given its sluggish revenue growth juxtaposed with legalization hopes and cost-cutting efforts. Wall Street analysts remain cautious, with most issuing "Hold" ratings and modest price targets, awaiting clearer evidence of accelerated revenue growth or significant regulatory shifts to justify a more bullish outlook.

https://www.ad-hoc-news.de/boerse/news/ueberblick/cronos-group-tobacco-cash-cannabis-crossroads-and-a-stock-market-in/68547358

Cronos Group Inc. (CRON): A Bull Case Theory

This article summarizes a bullish thesis on Cronos Group Inc. (CRON), focusing on the potential impact of marijuana reclassification as a Schedule III substance in the US. This regulatory change is expected to significantly improve CRON's financial performance by reducing tax burdens and allowing for normal operating expense deductions. The company's strategic backing from Altria Group and existing U.S. presence through PharmaCann position it well for long-term growth as the regulatory landscape evolves.

https://uk.finance.yahoo.com/news/cronos-group-inc-cron-bull-024852860.html

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy

Cronos Group Inc. has launched its premium cannabis brand, Lord Jones®, in Israel, introducing five indoor-grown flower strains to the medical cannabis market. This move is part of Cronos's borderless product strategy, leveraging Lord Jones's established reputation for quality and craftsmanship. The company plans to expand the brand's offerings in Israel with future special edition products.

https://www.globenewswire.com/news-release/2026/02/02/3230559/0/en/cronos-group-launches-premium-lord-jones-brand-in-israel-advancing-borderless-product-strategy.html

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy

Cronos Group Inc. has launched its Lord Jones® premium cannabis brand in Israel, introducing five indoor-grown flower strains to the medical cannabis market. This expansion is part of Cronos's borderless product strategy, leveraging the brand's reputation for quality and craftsmanship. The company aims to meet local demand in Israel with its meticulously produced and hand-packaged cannabis products, with plans for future special edition offerings.

https://www.manilatimes.net/2026/02/03/tmt-newswire/globenewswire/cronos-group-launches-premium-lord-jones-brand-in-israel-advancing-borderless-product-strategy/2270105

(CRON) Pivots Trading Plans and Risk Controls (CRON:CA)

This article provides trading plans and risk controls for Cronos Group Inc. (CRON:CA), including long and short positions with target prices and stop losses. It also presents AI-generated ratings for January 31, indicating a "Weak" short and mid-term outlook but a "Strong" long-term outlook. The piece encourages readers to obtain real-time triggers and includes a chart for CRON:CA, alongside links to numerous recent articles related to the stock.

https://news.stocktradersdaily.com/canada/cron-pivots-trading-plans-and-risk-controls_20260131_54e2b6

Trending Today

Ethereum ($ETH) Crypto Forecast: Up 5.6% Today

Solana ($SOL) Crypto Forecast: Up 7.9% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.1% Today

Albemarle Corporation ($ALB) Stock Forecast: Up 5.8% Today

Sonos Inc. ($SONO) Stock Forecast: Down 5.2% Today

Franco-Nevada Corp. ($FNV) Stock Forecast: Up 5.1% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Up 7.6% Today

Rocket Companies Inc ($RKT) Stock Forecast: Up 5.1% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Up 5.4% Today

Riot Platforms, Inc. ($RIOT) Stock Forecast: Up 6.5% Today

Cronos Group Inc. Price History

29.00.2026 - CRON Stock was down 7.0%

• Analysts at Canaccord Genuity Group issued a "buy" rating with a target price of C$4.25, indicating a possible upside. The general analyst consensus, however, continues to suggest a "Hold," with the average price target at $2.30.
• Although the company boasts a solid financial position with no debts and substantial cash reserves amounting to $824 million, concerns over a negative EPS forecast for the current fiscal year might have influenced the recent market decline.
• The company's strong operational performance and revenue growth in Q3 2025, largely propelled by the success of the Spinach brand and expansion initiatives, were somewhat overshadowed by uncertainties surrounding future profitability.
• The discussion of alternative AI stocks offering greater potential for market growth could have diverted investor focus from Cronos Group, contributing to its recent stock performance downturn.

19.11.2025 - CRON Stock was down 6.8%

• The bearish movement in CRON today could be attributed to profit-taking by investors after a series of significant stock price surges in response to the company's European expansion efforts.
• Despite the positive news of Cronos Group's strategic acquisition of CanAdelaar and its expansion into Europe, investors may be reevaluating the stock's valuation, which has been considered overvalued by some analysts.
• The high valuation and potential risks associated with delays or policy reversals in the cannabis sector may have contributed to the bearish sentiment towards CRON today.
• While the company's moves to capitalize on the evolving cannabis markets are promising, investors may be exercising caution amidst concerns about sustainability and profitability in the long term.

15.11.2025 - CRON Stock was down 5.0%

• Despite recent positive developments in Cronos Group's expansion into Europe and the surge in its stock price, today's bearish movement could be attributed to profit-taking by investors after a period of strong gains.
• Concerns about overvaluation and potential risks such as policy reversals or revenue growth delays might have contributed to the downward pressure on CRON's stock.
• Investors may be reevaluating their positions in CRON, considering the mixed financial metrics and the company's premium valuation compared to industry peers.
• While Cronos Group's strategic acquisitions and market expansions have generated positive feedback, market participants are likely being cautious amidst uncertainties in the cannabis sector and broader market conditions.

09.11.2025 - CRON Stock was up 6.4%

• The bullish movement in CRON stock today could be attributed to the strategic partnership announced between Crypto.com and 21shares to expand access to the Cronos ecosystem. This partnership is likely seen as a positive development for Cronos Group, potentially boosting investor confidence in the company's future prospects.
• Despite the slight dip in CRON shares recently, the overall market sentiment seems to have been positively influenced by the news of the strategic partnership. Investors may be focusing more on the long-term growth potential of Cronos Group rather than short-term fluctuations in share price.
• The announcement of new investment products tracking the Cronos token could have also contributed to the bullish movement, as it indicates increasing interest and adoption of Cronos' ecosystem, potentially driving up demand for the company's products and services.

22.11.2025 - CRON Stock was down 5.1%

• The stock fell on Wednesday, underperforming the overall market, which could be attributed to profit-taking or market correction.
• Despite being considered a safer bet in the cannabis industry due to its strong financial position and disciplined management, the high valuation and limited direct benefits from potential US cannabis rescheduling might have dampened investor enthusiasm.
• The company's improved gross margins and profitability could be overshadowed by the broader market sentiment or sector-specific challenges, leading to the bearish movement in the stock today.
• Investors may be reevaluating their positions in CRON amidst uncertainties surrounding cannabis regulations and market dynamics, contributing to the downward pressure on the stock price.

12.00.2026 - CRON Stock was up 2.6%

• Cronos' bullish movement was driven by its recent announcement of expanding into the Netherlands through the acquisition of Europe’s largest adult-use cannabis company. This strategic move is expected to unlock new revenue streams and enhance Cronos' position in the global cannabis market.
• Furthermore, positive trading plans and investment analysis on CRON:CA may have also influenced the stock's upward momentum. Analysts and AI-generated ratings suggesting buying at specific price levels and implementing stop-loss measures could have instilled confidence in investors.
• In conclusion, Cronos' strategic expansion initiatives, along with favorable trading recommendations and investment analysis, have instilled optimism among investors, triggering the significant bullish movement observed in the stock today.

03.01.2026 - CRON Stock was up 5.1%

• The bullish movement in CRON today can be attributed to the launch of its premium cannabis brand, Lord Jones®, in Israel. This strategic expansion into new markets with high-quality products showcases the company's commitment to growth and innovation.
• Additionally, the bullish thesis surrounding potential regulatory changes in the US, specifically the reclassification of marijuana as a Schedule III substance, has likely fueled investor optimism. This shift could lead to improved financial performance for CRON by reducing tax burdens and enhancing operational efficiency.
• Despite recent declines and cautious Wall Street analyst ratings, CRON's forward-thinking approach to product strategy and potential regulatory tailwinds seem to have resonated positively with investors, driving the stock's bullish momentum today.

29.08.2025 - CRON Stock was up 3.7%

• CRON experienced a strong bullish movement despite recent losses in market cap, showcasing resilience in the face of market challenges.
• The surge in CRON's stock price could be attributed to positive earnings reports or potential partnerships that have sparked investor optimism.
• Despite the recent setbacks and market fluctuations, CRON's bullish movement indicates that investors still see long-term potential in the company's growth prospects.
• The community's questioning of demand for Cronos products may have been overshadowed by positive developments within the company, leading to the bullish market movement.

29.08.2025 - CRON Stock was up 2.3%

• President Trump's support for CBD on Truth Social led to a surge in cannabis stock prices, including CRON.
• Despite the initial increase, CRON experienced a drop in market cap erasing the gains following Trump's post.
• There are concerns in the community regarding the demand for CRON after the market rally, indicating a possible shift in sentiment.
• The fluctuating movements in CRON following Trump's post highlight the unpredictable nature of cannabis stocks in response to political and regulatory developments.

28.07.2025 - CRON Stock was up 5.1%

• Cronos stock saw a notable upswing today, hitting a three-year peak, subsequent to the disclosure of a strategic partnership with Trump Media Group. This partnership entailed a substantial financial investment in Cronos through a $6.4 billion CRO treasury move.
• The collaboration with Trump Media Group, which involves the establishment of a CRO Strategy supported by a significant investment in CRO tokens, cash, warrants, and credit line, has sparked enthusiasm and confidence among investors regarding Cronos' future outlook.
• This strategic initiative not only injects a considerable sum of money into Cronos but also aligns the company with a reputable partner in the media industry, potentially paving the way for new growth opportunities and market expansion.
• The market's favorable response underscores Cronos' ability to capitalize on its position in the cannabis sector and explore innovative prospects in collaboration with strategic allies.

12.11.2025 - CRON Stock was up 8.2%

• CRON stock surged by 7.56% after acquiring CanAdelaar, Europe's largest adult-use cannabis company. This acquisition provides Cronos Group with a strong presence in the growing European market, leading to increased investor optimism.
• The company's strategic move into Europe's medical cannabis market and the acquisition of CanAdelaar are viewed as positive growth opportunities, driving up the stock price.
• Investors are analyzing the potential impact of this expansion on Cronos Group's market share and premium products, which have contributed to the bullish market movement.
• Despite regulatory risks in Europe, Cronos Group's CEO highlighted the financial and strategic significance of the expansion, boosting investor confidence in the company's future prospects.

10.11.2025 - CRON Stock was up 6.3%

• The positive market sentiment surrounding CRON stock is linked to its acquisition of CanAdelaar B.V., which expands Cronos Group's reach in the European adult-use cannabis market.
• Entering the European market is viewed as a strategic move to enhance Cronos's product development capabilities and global cannabinoid presence, attracting investor interest.
• The partnership with Crypto.com and 21shares is enhancing access to the Cronos ecosystem and creating new investment opportunities, contributing to the bullish momentum.
• Despite challenges like negative net margins and return on equity, Cronos Group's expansion efforts and strategic acquisitions have boosted investor confidence, reflected in the upward movement of its stock price.